Global Coronary Vascular Closure Devices Market Size By Type (Invasive Coronary VCDs, Non-Invasive Coronary VCDs), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Coronary Vascular Closure Devices Market was valued at USD 1.15 billion in 2023 and is projected to reach USD 2.34 billion by 2031, expanding at a CAGR of 9.1% from 2023 to 2031. This growth is driven by the increasing prevalence of cardiovascular diseases, the rising number of coronary catheterization procedures, and advancements in minimally invasive vascular closure technologies. As healthcare systems worldwide focus on reducing post-operative complications and hospital stays, the adoption of vascular closure devices for faster hemostasis and patient mobilization is accelerating.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

The growing global burden of coronary artery disease and other cardiovascular disorders has led to a surge in interventional procedures, particularly angiography and percutaneous coronary intervention (PCI). Vascular closure devices are essential in sealing arterial puncture sites post-procedure, improving recovery times.

2. Technological Advancements in Closure Devices:

Innovations such as bioabsorbable materials, suture-mediated systems, and extravascular plugs are enhancing device safety, efficacy, and patient comfort. These advancements are reducing complications like bleeding and vessel trauma.

3. Increasing Demand for Outpatient Interventions:

The trend toward same-day discharge and ambulatory cardiac procedures boosts demand for closure devices that offer rapid hemostasis and minimal recovery times.

Restraints:

1. Risk of Device-Related Complications:

Despite improvements, closure devices can still result in complications such as hematoma, infection, or device failure, particularly in high-risk patients, limiting widespread adoption in some cases.

2. High Cost of Advanced Closure Devices:

Premium-priced devices, especially those using advanced bioengineering, pose financial challenges for underfunded healthcare settings, limiting market penetration in price-sensitive regions.

Opportunity:

1. Emerging Markets and Healthcare Expansion:

The growing investment in healthcare infrastructure in developing nations, along with the rising awareness of cardiovascular health, presents a significant opportunity for market expansion in regions like Asia-Pacific and Latin America.

2. Integration with Digital Monitoring Platforms:

The integration of vascular closure procedures with real-time digital monitoring systems can help in post-operative care and improve outcomes, providing a value-added solution for healthcare providers.

Market by System Type Insights:

Based on system type, Extravascular Closure Devices held the largest share in 2023, driven by their lower complication rates and ease of use. These devices, which do not leave components inside the vessel, are gaining popularity for their safety profile. However, Suture-Based Closure Devices are also witnessing robust growth, particularly in procedures requiring large sheath sizes or in patients with peripheral vascular disease.

Market by End-Use Insights:

In terms of end use, Hospitals accounted for the largest market share in 2023 due to the high volume of cardiac catheterization labs and interventional procedures performed in these settings. However, Ambulatory Surgical Centers (ASCs) are expected to grow at a faster pace due to the global shift towards minimally invasive, outpatient cardiovascular procedures.

Market by Regional Insights:

North America led the market in 2023, supported by high procedural volumes, favorable reimbursement policies, and advanced healthcare infrastructure. Asia-Pacific is forecast to grow at the highest CAGR, driven by rising cardiovascular disease prevalence, increased healthcare spending, and growing access to interventional cardiology.

Competitive Scenario:

Leading players in the global coronary vascular closure devices market include:

Abbott Laboratories

Terumo Corporation

Cardinal Health, Inc.

Medtronic plc

Cardiva Medical, Inc. (Haemonetics Corporation)

Essential Medical, Inc.

Vivasure Medical Ltd.

Morris Innovative, Inc.

These companies are focusing on strategic acquisitions, product launches, and global expansion. For instance:

In 2024, Abbott launched a next-gen vascular closure system that uses bioresorbable extravascular technology for enhanced patient safety.

In 2023, Terumo announced the expansion of its vascular access solutions portfolio with new closure devices tailored for radial and femoral access.

Scope of Work – Global Coronary Vascular Closure Devices Market

Report Metric Details

Market Size (2023) USD 1.15 billion

Projected Market Size (2031) USD 2.34 billion

CAGR (2023-2031) 9.1%

Market Segments By System Type (Suture-Based, Extravascular, Collagen Plug-Based), By End-Use (Hospitals, Ambulatory Surgical Centers, Others)

Growth Drivers Rising cardiovascular disease prevalence, increasing number of catheterization procedures, and technological advancements

Opportunities Growing demand in emerging economies and integration with digital healthcare systems

Key Market Developments:

2023: Abbott received FDA approval for its new extravascular closure device aimed at reducing time to ambulation and minimizing complications.

2024: Haemonetics completed the acquisition of Cardiva Medical, expanding its portfolio in the vascular closure space.

2025: Terumo launched a hybrid closure system compatible with both small and large bore access sites.

FAQs:

1) What is the current market size of the Global Coronary Vascular Closure Devices Market?

The market size in 2023 was USD 1.15 billion.

2) What is the major growth driver of the Global Coronary Vascular Closure Devices Market?

The major growth driver is the rising prevalence of cardiovascular diseases and the growing adoption of minimally invasive interventional procedures.

3) Which is the largest region during the forecast period in the Global Coronary Vascular Closure Devices Market?

North America is expected to remain the largest region due to its advanced healthcare infrastructure and high procedural volume.

4) Which segment accounted for the largest market share in the Global Coronary Vascular Closure Devices Market?

The Extravascular Closure Devices segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Coronary Vascular Closure Devices Market?

Key players include Abbott, Terumo Corporation, Medtronic, Cardinal Health, and Haemonetics (Cardiva Medical), among others.

Would you like this report in Word or PDF format?